❭ Research by medical division ❭ Laboratory Medicine ❭ Dept. of Microbiology ❭ Genome instability in ageing and disease [Nilsen] ❭ Clinical trials

Clinical trials:

NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia

  • Link to home page at ClinicalTrials.gov
  • Hilde Loge Nilsen PI

Collaborator in:

  • NO-PARK studien (helse-bergen.no)
  • NO-ALS (NeuroSysMed.no)
  • NARNIA 
 
Scroll to top

Home Dept. of Microbiology Genome instability in ageing and disease [Nilsen]

  • Group members
  • Current projects
  • Clinical trials
  • Publications

Recent publications

Alsøe L, Brackmann SA, Liu Y, Wennerström AB, Esbensen QY, Kalyanasundaram S, Lefol Y, Domanska D, Andersen SN, Nilsen HL (2026)
The Role of Nuclear APOBEC Enzymes in Neoplastic Progression of Ulcerative Colitis
Clin Exp Gastroenterol, 19, 588161
DOI 10.2147/CEG.S588161, PubMed 42006844

Anwer D, A A, Marchi A, Kerkhoven E, Polster A (2026)
Network-based discovery of regulatory drivers of cognitive decline in alzheimer's disease
NPJ Aging, 12 (1)
DOI 10.1038/s41514-026-00443-0, PubMed 42463670

Arczewska KD, Kucharczyk M, Grzanka M, Życka-Krzesińska J, Białas A, Rybicka B, Kossowska H, Koblowska M, Bogusławska J, Nilsen H, Piekiełko-Witkowska A, Gellert R (2026)
Analysis of the SGLT2-independent off-target dapagliflozin activity using model organism Caenorhabditis elegans
Endokrynol Pol, 77 (3), 224-233
DOI 10.5603/ep.110917, PubMed 42222872

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)